Cardiologia

Perspectiva | Hidroclorotiazida vs. clortalidona – qual a diferença?

17 Out, 2022 | 12:56h

Hydrochlorothiazide Versus Chlorthalidone–What is the Difference? – Circulation (gratuito por tempo limitado)

Conteúdos relacionados:

Meta-analysis: Chlorthalidone vs. hydrochlorothiazide

Large Observational Study Suggests Hydrochlorothiazide may be as Effective as Chlortalidone with Less Adverse Effects

 

Comentário no Twitter

There are big differences among diuretics even within the same class. So let us rethink the class effect. https://t.co/ruE4IYeFf2. Here I discuss what we know about HCTZ vs CTD. pic.twitter.com/cyljdi04v9

— Rajiv Agarwal MD, MS (@AgarwalRajivMD) October 8, 2022

 

---

Diretriz científica AHA | Ciência da implementação na equidade da saúde cardiovascular.

17 Out, 2022 | 12:51h

Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association – Circulation

 

---

Recomendações de consenso para rastreamento e manejo de sobreviventes de câncer infantil quanto ao risco para cardiomiopatia.

17 Out, 2022 | 12:50h

Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy – JACC: CardioOncology

Conteúdos relacionados:

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors – Journal of Clinical Oncology

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) – European Heart Journal – Cardiovascular Imaging

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations – Annals of Oncology

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement from the American Heart Association – Circulation

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases – European Heart Journal. Acute Cardiovascular Care

Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia

AHA Statement: Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors

 

---

Oxigenação por membrana extracorpórea para choque cardiogênico: metanálise de mortalidade e complicações.

17 Out, 2022 | 12:48h

Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications – Annals of Intensive Care

 

---

Calculadora | Estimativa do risco individual para eventos cardiovasculares em adultos com diabetes tipo 2.

17 Out, 2022 | 12:43h

Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2) – European Journal of Preventive Cardiology

Ver também: DIAL Model Calculator

 

---

Estudo randomizado | Riociguate melhorou a hemodinâmica, mas aumentou intolerância na hipertensão pulmonar e insuficiência cardíaca com fração de ejeção preservada (HFpEF – heart failure with preserved ejection fraction).

17 Out, 2022 | 12:42h

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial – European Heart Journal

 

Comentário no Twitter

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: results of randomized, double-blind, placebo-controlled, multicentre trial out.https://t.co/FYmorikQR5#HFpEF #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/4sSeYt7Adq

— EHJ Editor-in-Chief (@ehj_ed) October 7, 2022

Sob licenca de https://creativecommons.org/licenses/by-nc/4.0/

 

---

M-A | Desfechos perinatais em gestações complicadas por cardiomiopatia materna.

17 Out, 2022 | 12:30h

Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: A systematic review and meta-analysis – American Journal of Obstetrics & Gynecology

 

---

Estudo de coorte | Vasculometria de retina habilitada por inteligência artificial para predição de doenças cardiovasculares.

6 Out, 2022 | 12:55h

Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke – British Journal of Ophthalmology

Editorial: The eyes as a window to the heart: looking beyond the horizon – British Journal of Ophthalmology

Comentário: AI eye checks can predict heart disease risk in less than minute, finds study – The Guardian

Conteúdos relacionados:

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.

Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.

 

---

Breve resumo | Como maximizar a diurese na insuficiência cardíaca aguda descompensada?

6 Out, 2022 | 12:53h

How do we maximize diuresis in acute decompensated heart failure? – Cleveland Clinic Journal of Medicine

Editorial: Decongesting heart failure with diuretics: Easier to prescribe than to fully understand – Cleveland Clinical Journal of Medicine

 

---

Breve resumo | Fibrilação atrial: controle da frequência ou controle do ritmo?

6 Out, 2022 | 12:51h

Atrial fibrillation: Rate control or rhythm control? – Cleveland Clinic Journal of Medicine

 

---